(WELL) HAN-GINS Indxx Healthcare - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000GEHNQU9 • Sector Equity Technology

WELL: Healthcare, Technology, Biotech, Pharmaceuticals

The HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (XETRA: WELL) is a Germany-domiciled ETF designed to provide exposure to the global healthcare sector, focusing on companies driving innovation and growth in medical technology, biotechnology, and healthcare services. The fund tracks the Morningstar Global Technology TME NR USD Index, which includes a diversified portfolio of equities across developed and emerging markets. With an AUM of 422.42M EUR, this ETF reflects investor interest in the long-term structural growth trends within the healthcare industry.

From a technical perspective, WELL has shown moderate trading activity, with an average 20-day volume of 4,320 shares. The ETF is currently trading at 19.44, slightly below its short-term SMA 20 of 19.85 and SMA 50 of 19.93, while remaining above its SMA 200 of 18.80. This indicates a neutral to slightly bearish short-term outlook but a bullish long-term trend. The ATR of 0.32 suggests relatively low volatility, making it appealing for risk-averse investors seeking stable exposure to the healthcare sector.

Over the next three months, based on and , WELL is expected to trade within a narrow range, with potential upside driven by continued innovation in the healthcare sector and downside risk mitigated by its diversified portfolio. The SMA 20 and SMA 50 are likely to act as key resistance levels, while the SMA 200 will provide support. Given the low ATR, price fluctuations are expected to remain muted, with an average daily range of 0.32. The ETFs AUM growth will continue to reflect investor sentiment toward healthcare equities, supported by strong fundamental themes such as aging populations and increased healthcare spending.

Additional Sources for WELL ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

WELL ETF Overview

Market Cap in USD 426m
Category Sector Equity Technology
IPO / Inception 2022-09-20

WELL ETF Ratings

Growth Rating 53.5
Fundamental -
Dividend Rating 49.5
Rel. Strength -3.57
Analysts -
Fair Price Momentum 13.96 EUR
Fair Price DCF -

WELL Dividends

Dividend Yield 12m 0.45%
Yield on Cost 5y 0.85%
Annual Growth 5y 89.74%
Payout Consistency 100.0%

WELL Growth Ratios

Growth Correlation 3m -88.2%
Growth Correlation 12m 25.6%
Growth Correlation 5y 93.6%
CAGR 5y 23.30%
CAGR/Max DD 5y 0.81
Sharpe Ratio 12m 1.18
Alpha -12.43
Beta 1.208
Volatility 40.91%
Current Volume 6.6k
Average Volume 20d 2.4k
What is the price of WELL stocks?
As of April 24, 2025, the stock is trading at EUR 15.52 with a total of 6,585 shares traded.
Over the past week, the price has changed by +0.60%, over one month by -13.15%, over three months by -23.89% and over the past year by -2.45%.
Is HAN-GINS Indxx Healthcare a good stock to buy?
Partly, yes. Based on ValueRay Analyses, HAN-GINS Indxx Healthcare (XETRA:WELL) is currently (April 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.53 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WELL as of April 2025 is 13.96. This means that WELL is currently overvalued and has a potential downside of -10.05%.
Is WELL a buy, sell or hold?
HAN-GINS Indxx Healthcare has no consensus analysts rating.
What are the forecast for WELL stock price target?
According to ValueRays Forecast Model, WELL HAN-GINS Indxx Healthcare will be worth about 15.6 in April 2026. The stock is currently trading at 15.52. This means that the stock has a potential upside of +0.58%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 15.6 0.6%